Skip to Content
Merck
  • Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanols.

Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanols.

British journal of pharmacology (2001-01-05)
C Lerche, G Seebohm, C I Wagner, C R Scherer, L Dehmelt, I Abitbol, U Gerlach, J Brendel, B Attali, A E Busch
ABSTRACT

Slowly activating I:(Ks) (KCNQ1/MinK) channels were expressed in Xenopous: oocytes and their sensitivity to chromanols was compared to homomeric KCNQ1 channels. To elucidate the contribution of the ss-subunit MinK on chromanol block, a formerly described chromanol HMR 1556 and its enantiomer S5557 were tested for enantio-specificity in blocking I:(Ks) and KCNQ1 as shown for the single enantiomers of chromanol 293B. Both enantiomers blocked homomeric KCNQ1 channels to a lesser extent than heteromeric I:(Ks) channels. Furthermore, we expressed both WT and mutant MinK subunits to examine the involvement of particular MinK protein regions in channel block by chromanols. Through a broad variety of MinK deletion and point mutants, we could not identify amino acids or regions where sensitivity was abolished or strikingly diminished (>2.5 fold). This could indicate that MinK does not directly take part in chromanol binding but acts allosterically to facilitate drug binding to the principal subunit KCNQ1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
HMR-1556, ≥98% (HPLC)